CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 106 enrolled
Drug / intervention
Escitalopramdrug
Likely dose
Escitalopram 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00754936
NCT00754936N/ACompleted

ERPs, Cognitive Dysfunction and Treatment Response of Geriatric Depression

Weill Medical College of Cornell University·interventional·Posted Sep 18, 2008·Updated Mar 19, 2019

In Brief

A clinical study evaluating Escitalopram for Depression. Completed, enrolled 106 participants across 1 site.

Detailed Summary

The purpose of this study is to examine the relationship between brain electrical activity in elderly depressed patients and response to antidepressant medication treatment. Elderly patients with depression will be treated for 12 weeks with an antidepressant medication commonly used in clinical practice called escitalopram (Lexapro). Brain electrical activity will be assessed using electrophysiological tests. Researchers are interested in whether the brain electrical activity of elderly people with depression before they start the medication can tell us who amongst them will improve with antidepressant treatment and to what extent. They will also determine whether patients' brain electrical activity during the 12 weeks of medication treatment will change in any way and whether this change will be linked with a change in the severity of their depression. Researchers hope that information gained from this study will help to better understand the brain processes associated with depression and its successful treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 18, 2008
Enrollment StartMay 1, 2007
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8 yearsPosted 17.8 years ago

Interventions

Escitalopramdrug

20 mg by mouth daily